GILEAD SCIENCES, INC. for GILEAD SCIENCES INC

Copyright/Patent/Trademark CPT

Issues related to pharmaceuticals and intellectual property protection including technology transfer, patent rights and funding.

Contacted: White House Office; Natl Institutes of Health (NIH); Commerce, Dept of (DOC); Patent & Trademark Office (PTO); State, Dept of (DOS); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); SENATE; Office of the Vice President of the United States; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS)

Taxation/Internal Revenue Code TAX

Proposals to change corporate tax rates and related laws

Contacted: Office of the Vice President of the United States; Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); White House Office; Health & Human Services, Dept of (HHS); State, Dept of (DOS); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); Natl Institutes of Health (NIH); Commerce, Dept of (DOC); SENATE; U.S. Trade Representative (USTR)

Health Issues HCR

Advocate on drug pricing proposals, expanding access to HIV treatment and prevention therapies including: Ryan White Care Act reauthorization; PEPFAR reauthorization; HIV/AIDS access to care, research, testing and treatment. Hepatitis C screening and linkage to care programs; coverage and reimbursement policy for Hepatitis C, HIV and oncology portfolio. Engage on pharmaceutical policy as it relates to payments under the 340B program. Highlight Gilead's efforts to ensure diversity in clinical trials. Issues related to developing treatments for COVID-19 (2019 Novel Coronavirus), including: manufacturing, clinical trials, reimbursement and coverage of Veklury (remdesivir). H.R.1319 - American Rescue Plan Act of 2021

Contacted: White House Office; Food & Drug Administration (FDA); Office of the Vice President of the United States; HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); SENATE; Commerce, Dept of (DOC); Natl Institutes of Health (NIH); State, Dept of (DOS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 1319 (117th)

Budget/Appropriations BUD

Funding for Hepatitis C, HIV, and public health activities via appropriations. H.R.1319 - American Rescue Plan Act of 2021

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Office of the Vice President of the United States; SENATE; White House Office; Natl Institutes of Health (NIH); Commerce, Dept of (DOC); Office of Management & Budget (OMB); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1319 (117th)

Veterans VET

Education related to antivirals and oncology products.

Contacted: Office of the Vice President of the United States; HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); State, Dept of (DOS); U.S. Trade Representative (USTR); White House Office; SENATE; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Advocate on drug pricing proposals. HCV testing, screening and linkage to care programs. Medicaid and Medicare coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products, including Medicare Part B proposals, and Medicare Part D reform and benefit redesign. CMS rules related to Notice of Benefit and Payment Parameters (NBPP), hospital inpatient payments, and Value-Based Purchasing arrangements.

Contacted: Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); State, Dept of (DOS); Patent & Trademark Office (PTO); Centers For Disease Control & Prevention (CDC); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Office of the Vice President of the United States; White House Office; HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); SENATE; Natl Institutes of Health (NIH)

Trade (domestic/foreign) TRD

International trade and protection of intellectual property; compulsory licensing and other IP issues in multiple countries.

Contacted: Patent & Trademark Office (PTO); Centers For Disease Control & Prevention (CDC); SENATE; White House Office; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Commerce, Dept of (DOC); Office of the Vice President of the United States; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Food & Drug Administration (FDA)